Literature DB >> 21523888

Angina pectoris in a patient with protein C deficiency and deep vein thrombosis: thrombus versus myxoma?

Shilpa Kshatriya1, Daniel Villarreal, Kan Liu.   

Abstract

A 55-year-old Caucasian man with history of hypertension, diabetes mellitus, protein C deficiency, and deep vein thrombosis presented with typical angina. Both computed tomography and transesophageal echocardiography identified a mobile mass in left atrium but could not differentiate between thrombus and myxoma. A cardiac catheterization with coronary angiography demonstrated tumor neovascularization, suggestive of myxoma. Pathology examination after mass resection confirmed the diagnosis. Patients with myxoma could present with obstructive, embolic, or constitutional symptoms. However, typical angina has never been reported as the primary manifestation. Although being helpful, various noninvasive imaging modalities, including magnetic resonance image, often have limitations to help making a definitive diagnosis, before surgery decision, especially under hypercoagulable condition. In contrast, cardiac catheterization can help not only in differentiation diagnosis but also in detecting possible intracoronary embolization from myxoma. In patients with myxoma complicated with hypercoagulable disorders, anticoagulation will play essential role in long-term care.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21523888     DOI: 10.1002/ccd.23102

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

Review 1.  Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era.

Authors:  Peter P Toth
Journal:  Vasc Health Risk Manag       Date:  2016-02-10

2.  Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis.

Authors:  Zehao Zhu; Yuanping Wang; Weilin Liao; Huimin Li; Dawei Wang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.